Introduction {#s1}
============

Sirtuins, a highly conserved family of nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylases, have been implicated as a key metabolic sensor to link dietary restriction (DR) with lifespan extension in yeast, worms, flies, and mice ([@bib39]). In yeast, silent information regulator 2 (Sir2), the founding member of the sirtuin family, mediates transcriptional silencing at the ribosomal DNA (rDNA) locus, mating type loci and telomeres by deacetylating the acetylated lysine 16 of histone H4 ([@bib46]; [@bib16]; [@bib51]; [@bib20]). Sir2 is thought to affect replicative aging of yeast cells by repressing recombination and instability at the rDNA ([@bib50]; [@bib11]; [@bib12]; [@bib55]; [@bib32]). In addition, Sir2 may regulate lifespan by deacetylating H4K16 at sub-telomeric regions ([@bib7]) and by asymmetrically segregating damaged proteins and cellular organelles between mother and daughter cells ([@bib1]; [@bib9]; [@bib41]). However, whether Sir2 mediates lifespan extension by DR in yeast is still under debate. Despite lots of reports supporting the role of Sir2 in DR-mediated lifespan extension ([@bib36], [@bib37]; [@bib2]; [@bib38]), numerous studies challenged the hypothesis ([@bib22]; [@bib25]; [@bib10]; [@bib52]). Similarly, in worms and flies, the role of Sir2 in lifespan extension is still controversial ([@bib59]; [@bib47]; [@bib33]; [@bib62]; [@bib4]; [@bib61]; [@bib3]; [@bib27]).

Here, we propose a new, potentially conserved, molecular mechanism of Sir2 in DR-mediated lifespan extension. Given the potential therapeutic implications of sirtuins, understanding the complex and controversial actions of sirtuins is one of central tasks in the sirtuin biology and aging field. We demonstrate that the phosphorylation of Sir2 at S473, which is regulated through cAMP-PKA and casein kinase 2 (CK2) signaling, determines the role of Sir2 in replicative lifespan (RLS).

Results {#s2}
=======

Deletion of *SIR2* is associated with loss of transcriptional silencing at sub-telomeric regions, sterility in haploids, destabilization of rDNA, and shortened lifespan ([@bib24]). We observed that *sir2*Δ mutant cells were more sensitive than the wild-type (WT) strain to high concentrations of NaCl and other monovalent cations, a phenotype not previously associated with loss of Sir2 ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A--C](#fig1s1){ref-type="fig"}). No sensitivity to divalent cations or osmotic stress was detected in the *sir2*Δ mutant ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). The NaCl sensitivity of the *sir2*Δ mutant was affected neither by Fob1, which increases the amount of extrachromosomal rDNA circles, nor by pseudodiploid state of the *sir2*Δ mutant strain ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).10.7554/eLife.09709.003Figure 1.Sir2 negatively regulates *PMA1* expression by deacetylating H4K16 in the *PMA1* promoter.(**A**) NaCl sensitivity of wild-type (WT), *sir2*∆, and *sir2*∆ cells expressing *SIR2*. (**B**) Plasma membrane potential as indicated by DiOC~6~ staining of WT and *sir2*∆ cells grown in glucose or ethanol medium (\*p \< 0.005). (**C**) *PMA1* mRNA levels in WT and *sir2*∆ cells measured by qRT-PCR (\*p \< 0.001). (**D**) Pma1 protein levels in WT and *sir2*∆ cells measured by Western blot (WB). (**E**) NaCl sensitivity of WT, *sir2*∆, and *sir2*∆ cells carrying WT *SIR2* or the *sir2-H364Y* mutant allele. (**F**) Silent information regulator 2 (Sir2) protein levels of the *SIR2*-overexpressing cells measured by WB. (**G**) NaCl sensitivity of the *SIR2*-overexpressing cells. (**H**) *PMA1* mRNA levels of the *SIR2*-overexpressing cells measured by qRT-PCR (\*p \< 0.02). (**I**) Sir2 enrichment at the *PMA1* promoter measured by Sir2 ChIP (\*p \< 0.001). (**J**) H4K16 acetylation levels at the *PMA1* promoter in WT and *sir2*∆ cells measured by AcH4K16 ChIP (\*p \< 0.02). Values in (**B**), (**C**), (**H**), (**I**), and (**J**) represent the average of at least three independent experiments (±S.D.).**DOI:** [http://dx.doi.org/10.7554/eLife.09709.003](10.7554/eLife.09709.003)10.7554/eLife.09709.004Figure 1---figure supplement 1.Sir2 is involved in regulation of monovalent cations in yeast.(**A**) *sir2*∆ mutant was sensitive to various monovalent cations and Hygromycin B, but not to divalent cation or osmotic stress, than WT. WT, *sir2*∆, *sir2*∆ cells transformed with an empty low-copy vector (pRS316) or pRS316 carrying the *SIR2* gene were spotted onto each plate as indicated and incubated at 30°C for 2 days. (**B**, **C**) *sir2*∆ mutants of all strains tested were more sensitive to NaCl (**B**) and LiCl (**C**) than WT in solid medium. (**D**) *PMA1* mRNA levels in *sir2*∆ mutants were higher than those in WT strains (\*, vs WT in an indicated strain, p \< 0.03). The values are the average of at least three independent experiments (±S.D.). (**E**) Pma1 protein levels in WT strains and their *sir2*∆ mutants were analyzed by Western blotting using an anti-Flag antibody. GAPDH protein was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.004](10.7554/eLife.09709.004)10.7554/eLife.09709.005Figure 1---figure supplement 2.The NaCl sensitivity of the *sir2Δ* mutant was affected neither by Fob1 nor by pseudodiploid state.(**A**) Deletion of *FOB1* gene does not affect NaCl sensitivity in WT and *sir2*∆. Each cell was spotted onto YPD plates with 0.8 M NaCl and incubated at 30°C for 3 days. (**B**) Deletion of *HMLα* from the *sir2*∆ mutant restored the mating phenotype. Each of mating type a cells (WT \[*URA3*\], *sir2*∆ \[*URA3*\], and *sir2*∆ *hml*∆ \[*URA3*\]) and *α* cells (BY4742) was seeded together into YPD medium at an initial OD~600~ = 0.2 and then incubated at 30°C for 1 day. Five μl of the cell culture was collected and spread onto synthetic minimal plate containing leucine and histidine. (**C**) Deletion of *HMLα* does not affect NaCl sensitivity in *sir2*∆ mutant. (**D**) Deletion of *HMLα* does not affect *PMA1* mRNA level in *sir2*∆ mutant. The *PMA1* mRNA level of each cell was analyzed by qRT-PCR (\*, vs WT in an indicated strain, p \< 0.005). (**E**) Addition of KCl did not rescue the NaCl sensitivity of *sir2*∆ cells. Each cell was spotted onto YPD plates containing 0.8 M NaCl with or without 0.2 M KCl and incubated at 30°C for 2 days.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.005](10.7554/eLife.09709.005)10.7554/eLife.09709.006Figure 1---figure supplement 3.Sir2 and Sas2 antagonistically regulate *PMA1* transcription in part through regulating H4K16 acetylation at *PMA1* promoter.(**A**) NaCl sensitivity of WT, *sir2*∆, *sas2*∆, and *sir2*∆ *sas2*∆ cells. Each cell was spotted onto YPD plates containing 0.8 M NaCl and incubated at 30°C for 3 days. (**B**) The *PMA1* mRNA levels of WT, *sir2*∆, *sas2*∆, and *sir2*∆ *sas2*∆ cells were analyzed by qRT-PCR. *ACT1* was used as a loading control. The values are the average of at least three independent experiments (±S.D.). p values were calculated using t-test. (**C**) Changes in H4K16 acetylation at the *PMA1* promoter were assayed by chromatin immunoprecipitation (ChIP) using an anti-H4K16 antibody in WT, *sir2*∆, *sas2*∆, and *sir2*∆ *sas2*∆ cells. 2 kb upstream region of the *PMA1* promoter (−2 kb) was used as a negative control for Sir2 action. *TEL-VIR* and *HMR* are known Sir2 targets. The values are the average of at least three independent experiments (±S.D.). p values were calculated using t-test. (**D**) Total H4K16 acetylation levels were analyzed by Western blotting using the anti-H4K16 antibody in WT, *sir2*∆, *sas2*∆, and *sir2*∆ *sas2*∆ cells. GAPDH protein was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.006](10.7554/eLife.09709.006)

Sir2 negatively regulates *PMA1* transcription by deacetylating H4K16 {#s2-1}
---------------------------------------------------------------------

The plasma membrane potential (Δ*Ψ*) is a critical determinant of cation tolerance ([@bib43]), and we reasoned that the NaCl sensitivity of the *sir2*Δ mutant could be due to hyperpolarization of the membrane. Indeed, relative to the WT strain, the *sir2*Δ mutant was more sensitive to the Δ*Ψ*-dependent antibiotic Hygromycin B ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) and had a higher Δ*Ψ* ([Figure 1B](#fig1){ref-type="fig"}). The high Δ*Ψ* in the *sir2*Δ mutant could result from at least two distinct mechanisms: decreased activity of the potassium uptake system ([@bib40]) or increased expression of *PMA1*, which encodes a plasma membrane H^+^-ATPase ([@bib49]). Reduced potassium uptake was unlikely to contribute to the membrane hyperpolarization because potassium chloride did not reverse the NaCl-sensitive phenotype of the *sir2*Δ mutant ([Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}). In contrast, we observed elevated levels of both *PMA1* mRNA and protein levels in *sir2*Δ cells, which could not be rescued by expression of the enzymatically inactive *sir2-H364Y* allele ([@bib58]) ([Figure 1C--E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1D,E](#fig1s1){ref-type="fig"}). Further, overexpression of Sir2 decreased NaCl sensitivity and Pma1 expression relative to WT cells ([Figure 1F--H](#fig1){ref-type="fig"}).

Given its role in transcriptional silencing ([@bib42]), we speculated that Sir2 might regulate *PMA1* expression by directly deacetylating H4K16 in the *PMA1* promoter region. Indeed, Sir2 binding at the *PMA1* promoter region was significantly greater than at another DNA fragment 2 kb upstream of the *PMA1* promoter, although it was not as great as at other Sir2-regulated sites, specifically *Tel-VIR* and *HMR* ([Figure 1I](#fig1){ref-type="fig"}). Accordingly, the H4K16 acetylation level in the *PMA1* promoter region was substantially higher in the *sir2*Δ mutant than in the WT strain ([Figure 1J](#fig1){ref-type="fig"}). We next tested whether Sas2, a major H4K16 acetyltransferase that antagonizes the effects of Sir2 on telomeric silencing and RLS in yeast ([@bib31]; [@bib57]; [@bib7]), opposes the Sir2-dependent H4K16 deacetylation in the *PMA1* promoter region. A *sas2*Δ mutant showed lower Pma1 mRNA levels and less H4K16 acetylation in the *PMA1* promoter region than WT cells ([@bib17]), although higher *PMA1* expression and H4K16 acetylation in a *sir2*Δ *sas2*Δ mutant suggest additional H4K16 acetyltransferases, for example, Esa1 ([@bib6]; [@bib56]; [@bib5]), replacing for Sas2 in the absence of Sir2 ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Taken together, these data support the model that Sir2 plays an important role in maintaining the Δ*Ψ* in yeast through regulation of *PMA1* expression via deacetylation of H4K16 in the *PMA1* promoter, while Sas2 antagonizes this function by acetylating H4K16 at this site.

cAMP-PKA signaling inhibits Sir2 activity for the transcriptional repression of *PMA1* through serine 473 phosphorylation {#s2-2}
-------------------------------------------------------------------------------------------------------------------------

Prior studies have shown that hyperactivation of the cyclic AMP (cAMP)-dependent protein kinase A (PKA) results in sensitivity to cellular stresses ([@bib53]) and NaCl ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), and PKA signaling has been proposed to negatively regulate Sir2 in response to glucose availability ([@bib36]). To examine the possibility that PKA is important for regulation of *PMA1* by Sir2, we deleted *PDE2*, encoding a high-affinity cAMP phosphodiesterase, which increased the intracellular cAMP level without affecting Sir2 expression ([Figure 2---figure supplement 1D--H](#fig2s1){ref-type="fig"}). The *pde2*Δ mutant was as sensitive to NaCl as the *sir2*Δ mutant and increased the Pma1 mRNA level as high as the *sir2*Δ mutant ([Figure 2A,B](#fig2){ref-type="fig"}). Furthermore, the addition of 8-Bromo-cAMP, a non-hydrolyzable cAMP analog, into the culture medium mimicked the effect of the *SIR2* deletion on *PMA1* expression ([Figure 2C](#fig2){ref-type="fig"}). To examine whether PKA is essential for *PMA1* regulation, we deleted *TPK1*, *TPK2*, and *TPK3*, the genes encoding the catalytic subunits of PKA, from the *pde2*Δ mutant strain. The Pma1 mRNA level in the *pde2*Δ *tpk1/2/3*Δ mutant strain was similar to that in WT ([Figure 2D](#fig2){ref-type="fig"}), therefore, we concluded that cAMP-PKA signaling controls the ability of Sir2 to regulate *PMA1* transcription.10.7554/eLife.09709.007Figure 2.cAMP-PKA signaling inhibits Sir2 activity for the transcriptional repression of *PMA1* and *RPGs* through serine 473 phosphorylation.(**A**) Effects of *PDE2* deletion on NaCl sensitivity. (**B**) Effects of *PDE2* deletion on *PMA1* expression measured by qRT-PCR (\*p \< 0.01). (**C**) Effects of 8-Bromo-cAMP addition on *PMA1* expression measured by qRT-PCR (\*p \< 0.01). (**D**) Effects of *TPK* deletion on *PMA1* expression in *pde2*∆ cells measured by qRT-PCR (\*p \< 0.01). (**E**) Sir2 enrichment at the *PMA1* promoter in WT and *pde2*∆ cells measured by Sir2 ChIP (NS, not significant). (**F**) H4K16 acetylation levels at the *PMA1* promoter in WT, *sir2*∆, and *pde2*∆ cells measured by AcH4K16 ChIP (\*p \< 0.001). (**G**) Sir2 phosphorylation levels in WT, *pde2*∆, and *pde2*∆ *tpk1/2/3*∆ cells analyzed by Phos-tag SDS-PAGE and WB. Arrowheads indicate cAMP-PKA-dependent phosphorylated (red) and non-phosphorylated (black) Sir2. The asterisk indicates cAMP-PKA-independent phosphorylation of Sir2. (**H**) Effects of *SIR2-S473E* or *SIR2-S473A* on *PMA1* expression in WT and *pde2*∆ cells measured by qRT-PCR (\*p \< 0.005). (**I**) Effects of *SIR2-S473E* or *SIR2-S473A* on H4K16 acetylation at the *PMA1* promoter in WT and *pde2*∆ cells measured by AcH4K16 ChIP (\*p \< 0.05). (**J**) Effects of *SIR2-S473E* or *SIR2-S473A* on the expression of ribosomal protein genes (*RPGs*) in WT and *pde2*∆ cells measured by qRT-PCR (\*p \< 0.005). (**K**) Effects of *SIR2-S473E* or *SIR2-S473A* on H4K16 acetylation at the *RPG* promoters in WT and *pde2*∆ cells measured by AcH4K16 ChIP (\*p \< 0.05). Values in (**B**), (**C**), (**D**), (**E**), (**F**), (**H**), (**I**), (**J**), and (**K**) represent the average of at least three independent experiments (±S.D.).**DOI:** [http://dx.doi.org/10.7554/eLife.09709.007](10.7554/eLife.09709.007)10.7554/eLife.09709.008Figure 2---figure supplement 1.The cAMP-PKA signaling-dependent effects of SIR2 deletion on NaCl sensitivity and *PMA1* expression.(**A**--**D**) The effect of *SIR2* deletion on NaCl sensitivity and *PMA1* expression in a sigma background 10560-2B strain is opposite to that in BY4741. The 10560-2B strain has hyperactive cAMP-PKA pathway, which confers an increased NaCl sensitivity to the strain. (**A**) NaCl sensitivity of WT and *sir2*∆ in BY4741 and 10560-2B. (**B**) Plasma membrane potential of WT and *sir2*∆ in BY4741 and 10560-2B (\*, vs WT in an indicated strain, p \< 0.005). (**C**) *PMA1* mRNA levels of WT and *sir2*∆ in BY4741 and 10560-2B measured by qRT-PCR (\*, vs WT in an indicated strain, p \< 0.0001). (**D**) Intracellular cAMP levels of WT and *sir2*∆ in BY4741, BY4741 *pde2*∆ and 10560-2B (\*p \< 0.005). (**E**--**H**) Reduction of cAMP/PKA signaling reversed the effect of *SIR2* deletion on the *PMA1* expression in 10560-2B strain. (**E**) Overview of the cAMP/PKA signaling pathway. (**F**) Effect of deleting either *RAS2* or *GPR1*, encoding an activator of adenylate cyclase or a G-protein glucose receptor, on the NaCl sensitivity of WT 10560-2B and *sir2∆* cells. (**G**) The *PMA1* mRNA levels of WT 10560-2B, *sir2*∆, *ras2*∆, and *sir2*∆ *ras2*∆ cells were analyzed by qRT-PCR. (**H**) Sir2 protein levels in WT and *pde2*∆ cells measured by WB. GAPDH protein was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.008](10.7554/eLife.09709.008)10.7554/eLife.09709.009Figure 2---figure supplement 2.Effect of sir2-S473A mutation on the phosphorylation of Sir2 in WT and pde2∆ cells.Sir2 proteins in WT, *sir2*∆, *pde2*∆, WT \[*sir2-S473-A*\], and *pde2*∆ \[*sir2-S473A*\] cells were IP with anti-Sir2 antibody and analyzed by WB as indicated. GAPDH protein was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.009](10.7554/eLife.09709.009)10.7554/eLife.09709.010Figure 2---figure supplement 3.cAMP-PKA signaling and phosphorylation of Sir2 at S473 regulate the expression of genes encoding ribosomal subunit proteins and cell size homeostasis.(**A**) Cell size of WT, *sir2*∆, and *pde2*∆ cells. Cells grown in YPD were harvested at an OD~600~ = 0.5. (**B**) Cell size of WT, *sir2*∆, *sir2*∆ *fob1*∆, and *sir2*∆ *hml*∆ cells. Cells grown in YPD were harvested at an OD~600~ = 0.5. (**C**) mRNA levels of RPGs in WT, *sir2*∆, and *pde2*∆ cells (\*, vs WT, p \< 0.005). The values are the average of at least three independent experiments (±S.D.). (**D**) Sir2 enrichment at the *RPL3* and *RPL5* promoters in WT, *sir2*∆, and *pde2*∆ cells (\*, vs WT, p \< 0.01). 2 kb upstream region of the *PMA1* promoter (−2 kb) was used as a negative control for Sir2 action. The values are the average of at least three independent experiments (±S.D.). (**E**) Effect of *SIR2-S473E* and *SIR2-S473A* on single cell size of WT and *pde2*∆ cells. Values correspond to the average single cell sizes measured for four independent cultures (\>150 cells for each culture).**DOI:** [http://dx.doi.org/10.7554/eLife.09709.010](10.7554/eLife.09709.010)

To investigate how cAMP-PKA signaling regulates Sir2 activity in the *PMA1* promoter, we measured the H4K16 acetylation level and the amount of Sir2 bound to the *PMA1* promoter in the *pde2*Δ mutant. The Sir2 binding efficiency was unaffected, but the H4K16 acetylation level was increased in the *pde2*Δ mutant ([Figure 2E,F](#fig2){ref-type="fig"}), suggesting that active cAMP-PKA signaling inhibits Sir2 activity but not Sir2-binding efficiency. To investigate how cAMP-PKA signaling inhibits Sir2 activity, we analyzed the phosphorylation of Sir2 in WT, *pde2*Δ, and *pde2*Δ *tpk1/2/3*Δ cells. The *pde2*Δ cells showed more Sir2 phosphorylation than the WT and *pde2*Δ *tpk1/2/3*Δ cells, suggesting that active cAMP-PKA signaling increases Sir2 phosphorylation ([Figure 2G](#fig2){ref-type="fig"}).

We examined whether Sir2 S473, a conserved phosphorylation site in all known Sir2 homologs ([@bib13]), is responsible for the regulation of Sir2 deacetylase activity. Mutation of the S473 residue to alanine (Sir2-S473A) abolished the Sir2 phosphorylation induced by cAMP-PKA signaling ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Moreover, the Pma1 mRNA level increased in WT cells expressing the phospho-mimetic Sir2-S473E protein and decreased in *pde2*Δ cells expressing the phospho-deficient Sir2-S473A protein, matching the respective levels in WT and *pde2*Δ cells expressing WT Sir2 ([Figure 2H](#fig2){ref-type="fig"}). Consistently, the occupancy of H4K16 acetylation in the *PMA1* promoter region was higher in the WT cells expressing Sir2-S473E and lower in the *pde2*Δ cells expressing Sir2-S473A than that in the cells expressing WT Sir2 ([Figure 2I](#fig2){ref-type="fig"}). Those results suggest that Sir2 S473 is phosphorylated in response to cAMP-PKA signaling, and that phosphorylated Sir2 is unable to repress *PMA1* transcription.

Sir2 regulates transcription of ribosomal protein genes in a cAMP-PKA-dependent manner {#s2-3}
--------------------------------------------------------------------------------------

We observed that deletion of *SIR2* or *PDE2* resulted in cell size increase, which was not associated with rDNA destabilization or pseudodiploid state of the *sir2*Δ mutant strain ([Figure 2---figure supplement 3A,B](#fig2s3){ref-type="fig"}). Because ribosome biosynthesis rate can affect yeast cell size ([@bib23]) and Sir2 associates with actively transcribed genes ([@bib60]; [@bib35]), including *PMA1* and ribosomal protein genes (RPGs) ([@bib60]), we reasoned that Sir2 might regulate the expression of ribosomal proteins. The mRNA levels of many RPGs were higher in *sir2*Δ and *pde2*Δ cells than in WT cells ([Figure 2---figure supplement 3C](#fig2s3){ref-type="fig"}). Because the amount of Sir2 bound to the *RPL3* and *RPL5* promoters was not changed in the *pde2*Δ mutant ([Figure 2---figure supplement 3D](#fig2s3){ref-type="fig"}), we thought that the cAMP-PKA-dependent phosphorylation of Sir2 is also responsible for the repression of RPGs transcription as shown in the *PMA1* regulation. WT cells expressing Sir2-S473E produced more RPG (*RPL3*, *RPL5*, and *RPS0A*) mRNAs than WT cells expressing WT Sir2, and *pde2*Δ cells expressing Sir2-S473A produced fewer RPG mRNAs than *pde2*Δ cells expressing WT Sir2 ([Figure 2J](#fig2){ref-type="fig"}). Consistent with the increased amounts of RPG mRNAs, the relative occupancy of H4K16 acetylation in the RPG promoters was higher in the *sir2*Δ, *pde2*Δ, and *SIR2-S473E* cells than in the WT cells ([Figure 2K](#fig2){ref-type="fig"}). The expression of Sir2-S473E in WT cells, or that of Sir2-S473A in *pde2*Δ cells, reversed the cell size of each strain ([Figure 2---figure supplement 3E](#fig2s3){ref-type="fig"}). These observations suggest that Sir2 regulates the transcription of many RPGs in a cAMP-PKA-dependent manner.

*CKA2* mediates cAMP-PKA-dependent Sir2 phosphorylation {#s2-4}
-------------------------------------------------------

Because the amino acid residues flanking Sir2 S473 do not constitute a PKA consensus motif, other kinases downstream of PKA may be involved in S473 phosphorylation. We screened a collection of yeast kinase--gene deletions consisting of 121 mutant strains ([Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}) and selected 21 kinase mutants that grew better than WT cells in medium containing 0.8 M NaCl. Among these, we focused on *CKA2*, *KSS1*, and *DBF2*, because those three kinases are known to localize in the nucleus and the sensitivity of each of the corresponding deletion mutants to NaCl was increased in the presence of nicotinamide, a Sir2 inhibitor ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}). Only the *CKA2* deletion decreased NaCl sensitivity and the *PMA1* and *RPL3* mRNA levels of the *pde2*Δ mutant ([Figure 3A--D](#fig3){ref-type="fig"} and [Figure 3---figure supplements 1C--F, 2](#fig3s1 fig3s2){ref-type="fig"}), and the phospho-mimetic Sir2-S473E protein increased NaCl sensitivity, cell size, and *PMA1* and *RPL3* mRNA levels of the *cka2*Δ mutant ([Figure 3E--G](#fig3){ref-type="fig"}). The *CKA2* deletion reduced the phosphorylation of Sir2, which was significantly increased in the *pde2*Δ mutant ([Figure 3H](#fig3){ref-type="fig"}), and the increased interaction of Cka2 with Sir2 in the *pde2*Δ mutant was reversed in the absence of the *TPK* genes ([Figure 3I](#fig3){ref-type="fig"}). Furthermore, chromatin immunoprecipitation analysis revealed that Cka2 binding to the *PMA1* and *RPL3* promoter regions, but not to other Sir2 target sites including *Tel-VIR* and *HMR*, was increased in the *pde2*Δ mutant but decreased in the *pde2*Δ *tpk1/2/3*Δ mutant ([Figure 3J](#fig3){ref-type="fig"}). Collectively, those results support the hypothesis that Cka2 works downstream of PKA to phosphorylate Sir2 bound to the *PMA1* promoter region.10.7554/eLife.09709.011Figure 3.*CKA2* mediates cAMP-PKA-dependent Sir2 phosphorylation to regulate the expression of *PMA1* and RPGs.(**A**, **B**) Effects of *CKA2* deletion on NaCl sensitivity in WT (**A**), *sir2*∆ (**A**), and *pde2*∆ cells (**B**). (**C**, **D**) Effects of *CKA2* deletion on the expression of *PMA1* (**C**) and *RPL3* (**D**) in WT, *sir2*∆, and *pde2*∆ cells measured by qRT-PCR (\*p \< 0.01). (**E**) Effects of *SIR2-S473E* or *SIR2-S473A* on NaCl sensitivity in WT and *cka2*∆ cells. (**F**, **G**) Effects of *SIR2-S473E* or *SIR2-S473A* on the expression of *PMA1* (**F**) and *RPL3* (**G**) in WT and *cka2*∆ cells measured by qRT-PCR (\*p \< 0.005). (**H**) Sir2 phosphorylation levels in WT, *pde2*∆, and *pde2*∆ *cka2*∆ cells. Myc-tagged Sir2 proteins were immunoprecipitated (IP) and analyzed by WB as indicated. (**I**) In vivo Sir2 and Cka2 interaction in WT, *pde2*∆, and *pde2*∆ *tpk1/2/3*∆ cells. Flag-tagged Cka2 proteins (Cka2-Flag) were IP and analyzed by WB. (**J**) Cka2-Flag enrichment at the *PMA1* promoter in WT, *pde2*∆, and *pde2*∆ *tpk1/2/3*∆ cells measured by Flag ChIP (\*p \< 0.001). Values in (**C**), (**D**), (**F**), (**G**), and (**J**) represent the average of at least three independent experiments (±S.D.). NaCl sensitivity of the 121 kinase mutant strains used to identify kinases required for protein kinase A (PKA)-dependent Sir2 phosphorylation is available in the [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.011](10.7554/eLife.09709.011)10.7554/eLife.09709.012Figure 3---source data 1.NaCl sensitivity of the kinase mutant strains.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.012](10.7554/eLife.09709.012)10.7554/eLife.09709.013Figure 3---figure supplement 1.Sir2-mediated NaCl sensitivity of kinase mutant strains.(**A**) NaCl sensitivity of kinase mutant strains. (**B**) Effect of nicotinamide treatment on the NaCl sensitivity of 21 kinase mutants. Each cell was spotted onto YPD plates containing 0.8 M NaCl with or without 5 mM nicotinamide and incubated at 30°C for 2 days. (**C**, **D**) Effect of *KSS1* deletion on the NaCl tolerance in WT (**C**), *sir2*∆ (**C**), and *pde2*∆ (**D**). (**E**, **F**) Effect of *DBF2* deletion on the NaCl tolerance in WT (**E**), *sir2*∆ (**E**), and *pde2*∆ (**F**).**DOI:** [http://dx.doi.org/10.7554/eLife.09709.013](10.7554/eLife.09709.013)10.7554/eLife.09709.014Figure 3---figure supplement 2.Effect of cka2∆ or sir2-S473E mutation on cell size of WT and pde2∆ mutant cells.WT, *cka2*∆, *cka2*∆ \[*sir2-S473E*\], *pde2*∆, and *pde2*∆ *cka2*∆ cells were grown in YPD and harvested at an OD~600~ = 0.5. Cell sizes were measured for at least 250 unbudded single cells.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.014](10.7554/eLife.09709.014)

Sir2 S473 phosphorylation inhibits DR-mediated lifespan extension by Sir2 {#s2-5}
-------------------------------------------------------------------------

Since DR is known to reduce cAMP-PKA activity ([@bib36]) and both *PMA1* and RPGs are critical regulators of yeast RLS ([@bib54]; [@bib21]; [@bib18]), we investigated the relevance of Sir2 S473 phosphorylation in the DR-mediated lifespan extension. The RLS in 2% glucose medium of the *SIR2-S473A* and *SIR2-S473E* cells was about 20% longer and about 10% shorter, respectively, than that of the WT cells ([Figure 4A](#fig4){ref-type="fig"}). The short RLS of the *pde2*Δ cells was increased by the *SIR2-S473A* allele to equal that of the WT cells in 2% glucose medium ([Figure 4B](#fig4){ref-type="fig"}). The *SIR2-S473A* allele had no effect on the RLS in 0.5% glucose medium ([Figure 4C](#fig4){ref-type="fig"}), however, which is in agreement with the *PMA1* and *RPL3* mRNA levels ([Figure 4D,E](#fig4){ref-type="fig"}). In addition, the effect of Sir2 S473 phosphorylation on RLS of yeast cells was independent of rDNA recombination/stability ([Figure 4F,G](#fig4){ref-type="fig"}). Collectively, those results suggest that the phosphorylation of Sir2 S473 inhibits DR-mediated lifespan extension by Sir2.10.7554/eLife.09709.015Figure 4.Sir2 S473 phosphorylation inhibits DR-mediated lifespan extension by Sir2.(**A**) Replicative lifespan (RLS) of the strains expressing *SIR2-S473E* or *SIR2-S473A* measured by micromanipulation. The median lifespan is indicated. p \< 0.0001 (WT vs *sir2*Δ), p = 0.0013 (WT vs *sir2*-*S473E*), p = 0.0062 (WT vs *sir2*-*S473A*). (**B**) Effect of *SIR2-S473A* on the RLS of *pde2*∆ cells. The median lifespan is indicated. p \< 0.0001 (WT vs *pde2*Δ), p \< 0.0001 (*pde2*Δ vs *pde2*Δ *sir2*-*S473A*). (**C**) RLS of WT, *sir2*∆, and strains expressing *SIR2-S473E* or *SIR2-S473A* grown under 0.5% glucose conditions. The median lifespan is indicated. p \< 0.0001 (WT vs *sir2*Δ), p = 0.0006 (WT vs *sir2*-*S473E*), p = 0.5051 (WT vs *sir2*-*S473A*). (**D**, **E**) Effects of *SIR2-S473A* on the expression of *PMA1* (**D**) and *RPL3* (**E**) in cells grown under 2.0%, 0.5%, or 0% glucose conditions measured by qRT-PCR (\*p \< 0.005). The values represent the average of at least three independent experiments (±S.D.). (**F**, **G**) Effects of *SIR2-S473E* or *SIR2-S473A* on the RLS of *fob1*∆ background under 2% (**F**) and 0.5% (**G**) glucose conditions. The median lifespan is indicated. p \< 0.0001 (*fob1*∆ vs *sir2*Δ under 2.0% glucose), p \< 0.0001 (*fob1*∆ vs *sir2*-*S473E* under 2.0% glucose), p = 0.0002 (*fob1*∆ vs *sir2*-*S473A* under 2.0% glucose), p \< 0.0001 (*fob1*∆ vs *sir2*Δ under 0.5% glucose), p \< 0.0001 (*fob1*∆ vs *sir2*-*S473E* under 0.5% glucose), p = 0.3221 (*fob1*∆ vs *sir2*-*S473A* under 0.5% glucose). (**H**) A working model for how Sir2 regulates dietary restriction (DR)-mediated lifespan in yeast.**DOI:** [http://dx.doi.org/10.7554/eLife.09709.015](10.7554/eLife.09709.015)

Discussion {#s3}
==========

In this study, we propose a new, potentially conserved, molecular mechanism of Sir2 in DR-mediated lifespan extension ([Figure 4H](#fig4){ref-type="fig"}). We show that Sir2 is able to increase RLS of yeast cells only under conditions where cAMP-PKA and CK2 signaling is not active. This result suggests that the role of Sir2 in DR-mediated lifespan extension depends on the metabolic status of cells, which is also supported by our previous report that the role of Sir2 in mediating oxidative stress resistance and chronological lifespan is growth-phase dependent ([@bib29]). We speculate that a similar paradigm may exist in higher eukaryotes, although the functions and molecular mechanisms of sirtuins are much more complex, because Sir2 S473 is a conserved phosphorylation site in all known sirtuins ([@bib13]) and numerous papers report the genetic and molecular interaction between cAMP-PKA and CK2 and SirT1 phosphorylation in mammalian cells ([@bib28]; [@bib63]; [@bib13]; [@bib8]; [@bib45]; [@bib34]).

We also demonstrate that Sir2 fine-tunes transcription of the *PMA1* and RPGs by deacetylating H4K16 in the promoter. This finding indicates that Sir2-dependent H4K16 deacetylation plays a role in the regulation of actively transcribed genes in addition to the silencing of the rDNA locus, mating type loci, and telomeres in yeast. Considering previous studies showing that Sir2 binds on actively transcribed genes including *PMA1* and RPGs in yeast ([@bib60]; [@bib35]), we expect this result will open a new perspective about the molecular functions of Sir2.

Pma1 protein level increases almost twofold in the absence of Sir2 ([Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). Recent reports indicate that vacuolar acidity is functionally linked with mitochondria and autophagy, which have a central role in the aging process ([@bib19]; [@bib48]). And, vacuolar acidity declines in aging yeast cells because of Pma1 accumulation that reduces cytosolic protons ([@bib18]). It is thought that Pma1 expression affects yeast cell aging by changing intracellular pH, vacuolar pH, amino acid import into vacuole, and mitochondrial function ([@bib19]; [@bib18]). Thus, our study suggests a possibility that Sir2 contributes to DR-mediated lifespan extension at least in part by affecting mitochondrial function through cytoplasmic and vacuolar pH regulation in a context-dependent manner.

Materials and methods {#s4}
=====================

Yeast strains and growth conditions {#s4-1}
-----------------------------------

The yeast strains used in the study are listed in [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. The experiments were performed using the BY4741 strain, unless otherwise noted. The 10560-2B strain was used to compare and confirm the results obtained with the BY4741 strain. Deletion strains were generated by replacing each open reading frame with *URA3* through homologous recombination. To confirm the effects of *SIR2* mutations on stress resistance, a centromeric plasmid (pRS316) containing the *SIR2* promoter (−1000 to −1), the entire *SIR2* gene, and the *ADH1* terminator was introduced into a *sir2*∆ mutant strain. To generate the *SIR2* overexpression strains, a fragment that included a *SIR2* promoter, an entire *SIR2* gene, an *ADH1* terminator, and *URA3* was integrated at the *URA3* locus of WT or *pde2*∆ strains by homologous recombination. To generate strains expressing a Sir2 protein with no deacetylase activity (sir2-H364Y) or a mutated phosphorylation site (sir2-S473E or sir2-S473A), fragments that included a *SIR2* promoter, each mutated *SIR2* gene, an *ADH1* terminator, and *URA3* were integrated at the endogenous *SIR2* promoter locus in the *sir2*∆, *pde2*∆ *sir2*∆, or *cka2*∆ *sir2*∆ mutant strains by homologous recombination. To facilitate Western blotting and immunoprecipitation experiments, endogenous *SIR2*, *PMA1*, and *CKA2* were tagged at the C-terminus with *13 MYC*-*URA3* or *FLAG*-*URA3* fragment by homologous recombination. All strains generated in this study were verified using PCR and/or Western blotting.

Yeast cells were routinely grown in YPD (1% yeast extract, 2% peptone, and 2% glucose) at 30°C. Synthetic complete medium lacking uracil was used for the selection of *URA*^+^ strains. When required, transformants were plated onto solid medium containing 5′-fluoroorotic acid (1 mg/ml) to select for the loss of the *URA3* marker.

Stress resistance test {#s4-2}
----------------------

Yeast cells were grown in YPD medium at 30°C for 1 day and then seeded into 25--50 ml YPD medium at an initial OD~600~ = 0.2 and incubated to log phase. One milliliter of the cell culture was collected, and the cells were washed with distilled water, diluted, and spotted onto regular YPD or YPD containing various concentrations of chemicals (for cationic stress: 0.15--1.2 M NaCl, 0.2--0.8 M KCl, 0.5 M LiCl, 50 mM CsCl, 5 mM--1 M CaCl~2~, or 300 μg/ml Hygromycin B; for osmotic stress: 1 M sorbitol or 1 M mannitol; for acidic stress: 50 mM citrate buffer \[pH 3.5\]). The cells were incubated for 2--3 days at 30°C, and the plates were photographed.

Measurement of plasma membrane potential {#s4-3}
----------------------------------------

The relative plasma membrane potential of each strain was measured as described previously ([@bib40]). Briefly, cells were grown in YPD (OD~600~ \< 0.5), harvested, resuspended to OD~600~ = 0.1 in PBS (Phosphate-buffered saline) buffer, and exposed to 1 nM DiOC~6~(3) cyanine dye (3,3′-dihexyloxacarbocynine iodide, Molecular Probes, Eugene, OR) for 30 min at 30°C in the dark. The fluorescence values were calculated by flow cytometer (Becton Dickinson, San Jose, CA). All measurements were made at least three times using independent preparations.

Preparation of whole-cell extracts and Western blotting {#s4-4}
-------------------------------------------------------

Total cell extracts were prepared using the TCA method ([@bib30]). Proteins were separated on 8--15% SDS-PAGE gels and transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA). The membranes were probed with specific antibodies, and immuno-reactivity was detected using enhanced chemiluminescence reagent (Elpis Biotech, Korea). The primary antibodies were anti-Sir2 (1:200, Santa Cruz, Dallas, TX), anti-FLAG (1:1000, Sigma, Saint Louis, MO), anti-Myc (1:1000, Santa Cruz), anti-GAPDH (1:10,000, Acris, Germany), anti-AcH4K16 (1:2000, Upstate, Lake Placid, NY), and anti-H4 (1:0000, Millipore). Band density trace and quantification were determined using ImageJ (National Institutes of Health).

Phos-tag SDS-PAGE and immunoprecipitation {#s4-5}
-----------------------------------------

To detect phosphorylated Sir2 proteins, total cell extracts were separated on 6% SDS-PAGE gels containing 25 mM Phos-tag (Wako, Japan) and 100 mM MnCl~2~ as recommended by the supplier and analyzed by Western blot (WB) with anti-Sir2 antibody (1:200, Santa Cruz). Band intensities were quantified using ImageJ software (National Institutes of Health). Sir2 phosphorylation levels were calculated by subtracting the up-shifted Sir2 protein levels detected by Phos-tag SDS-PAGE from the total Sir2 protein levels of the same sample detected by normal SDS-PAGE. Alternatively, Sir2-13Myc proteins were immunoprecipitated (IP) using an anti-Myc antibody (1:100, Santa Cruz) and then analyzed by WB with anti-Phosphoserine antibody (1:100, Qiagen, Valencia, CA).

To investigate the interaction between Sir2 and Cka2 in vivo, cells expressing Flag-tagged Cka2 were resuspended in lysis buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton-100, 1 mM PMSF, 1 mM Na~3~VO~4~, and 1 mM NaF) and lysed using glass beads with vigorous vortexing. The lysates were IP overnight using anti-Sir2 antibody (1: 100, Santa Cruz) and 20 µl Protein A/G agarose beads (Santa Cruz). The beads were then washed five times with lysis buffer, and the proteins bound to the beads were analyzed by WB with anti-FLAG antibody (1:1000, Sigma).

cAMP extraction and determination {#s4-6}
---------------------------------

The method for cAMP extraction using TCA was modified from a protocol for ATP extraction ([@bib15]). Briefly, 2 × 10^8^ cells (20 ml culture with OD~600~ = 0.5) were pelleted, washed, and resuspended in 1 ml cold milliQ-water. Metabolites were extracted by adding 1.2 ml TCA (0.5 M) and vigorously vortexing while the samples were kept on ice for 15 min. TCA was removed by ether extraction. The cAMP levels in the extracts were determined using cAMP Direct Immunoassay Kit (Biovision, San Francisco, CA) as recommended by the supplier. The values were normalized to dry cell weight.

RNA isolation, cDNA synthesis, and real-time PCR analysis {#s4-7}
---------------------------------------------------------

Total RNA was purified with the RNeasy Mini kit (Qiagen) and quantified by measuring the absorbance at 260 nm. From each 0.5 µg RNA sample, cDNA was synthesized using First Strand cDNA synthesis kit (Invitrogen, Carlsbad, CA) according to the manufacturer\'s recommendations and analyzed by quantitative RT-PCR with the oligonucleotides described in [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}. Real-time PCR was performed with SYBR green PCR mix (Bio-Rad) and CFX connect system (Bio-Rad, Hercules, CA). Relative expression levels (normalized to *ACT1*) were determined using the comparative CT method.

Chromatin immunoprecipitation {#s4-8}
-----------------------------

All chromatin immunoprecipitation (ChIP) assays were performed at least in triplicate using independent chromatin preparations. The ChIP assay was carried out essentially as described ([@bib44]). Briefly, cells were fixed by 1% formaldehyde (Sigma) for 1 hr and quenched in 125 mM glycine. Cells were harvested and lysed using glass beads with vigorous vortexing, and the lysates were sonicated at 4°C for 10 cycles of 1 min on and 1 min off. Then, the supernatant was IP with anti-Sir2 antibody (Santa Cruz), anti-AcH4K16 antibody (Abcam, Cambridge, MA), or anti-FLAG antibody (Sigma) followed by incubation with BSA-coated Protein A/G agarose beads (Santa Cruz). The crosslinks were reversed, and IP DNA was precipitated and purified. Quantitative real-time PCR was performed to amplify specific regions using each oligonucleotide described in [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}.

Cell size measurement {#s4-9}
---------------------

Cells were harvested at an OD~600~ ∼0.5, and the average area of the unbudded single cells was measured from microscopic images of approximately 150 cells per sample using ImageJ software (National Institutes of Health).

Screening of the yeast kinase--gene deletion collection {#s4-10}
-------------------------------------------------------

To identify kinases required for PKA-dependent Sir2 phosphorylation, we screened 121 mutant strains harboring kinase deletions in the BY4741 background for resistance to NaCl. The strains were first grown in 100 µl YPD containing 150 µg/ml G418 (Gibco-BRL, Rockville, MD) in 96-well plates at 30°C with vigorous shaking (240 rpm) for 1 day and then inoculated into 50 µl regular YPD or YPD containing 0.8 M NaCl in 96-well plates using a 96-pin replicator (V&P Scientific, San Diego, CA). The plates were incubated at 30°C with vigorous shaking (240 rpm), and the OD~600~ of each well was read every 1 hr for 9 hr using a microplate reader (Bio-Rad). The NaCl resistance of each strain was calculated on the basis of growth in YPD containing 0.8 M NaCl relative to that in regular YPD ([Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). The NaCl-resistant mutants identified during the screening were further tested for Sir2-dependence of the NaCl resistance using a spotting assay with serial dilution on plates containing 5 mM nicotinamide (Sigma).

Yeast lifespan determination {#s4-11}
----------------------------

The RLSs of the yeast strains were determined by micromanipulation as previously described ([@bib26]) using 50--100 virgin cells grown on standard YPD plates containing 2% or 0.5% glucose. Statistical significance of the difference in the RLS between strains was determined by a two-tailed Wilcoxon rank-sum test (p \< 0.05).

Funding Information
===================

This paper was supported by the following grant:

-   http://dx.doi.org/10.13039/501100003725National Research Foundation of Korea 2010-0013086 to Jeong-Yoon Kim, Ki-Sun Kwon.

We thank Matt Kaeberlein at University of Washington, Brian Kennedy at Buck Institute, and Joon Ho Lee and Cheon Ah Kim at Seoul National University for critical reading of the manuscript and valuable comments and to Won Ki Hur at Seoul National University for providing yeast deletion library. We are grateful to Ji Young Lee and Young Eun Kim for experimental assistance. This research was supported by grants from Korean Research Foundation (2010-0013086) and the Bio & Medical Technology Development Program (2013M3A9B6076413) of National Research Foundation funded by the Korean government (MSIP).

Additional information {#s5}
======================

The authors declare that no competing interests exist.

WKK, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

YHK, Acquisition of data, Analysis and interpretation of data.

HAK, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

K-SK, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

J-YK, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

Additional files {#s6}
================

10.7554/eLife.09709.016

###### 

Strains used in the study.

**DOI:** [http://dx.doi.org/10.7554/eLife.09709.016](10.7554/eLife.09709.016)

10.7554/eLife.09709.017

###### 

Primers used in the study.

**DOI:** [http://dx.doi.org/10.7554/eLife.09709.017](10.7554/eLife.09709.017)

10.7554/eLife.09709.018

Decision letter

Tyler

Jessica K

Reviewing editor

University of Texas MD Anderson Cancer Center

,

United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled "cAMP-PKA and CK2 Signaling Determines a Novel Lifespan Extension Activity of Sir2 in Yeast" for peer review at *eLife*. Your submission has been favorably evaluated by Jim Kadonaga (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another, and the Reviewing editor has drafted this decision to help you prepare a revised submission. All reviewers felt that the work was interesting, important and thorough. However, there were multiple technical points that would need to be addressed prior to publication in *eLife*.

Essential revisions:

1\) Despite the title, the only experiment on life span extension, in the last figure, is wrongly interpreted. The lifespan data show that phosphorylation of Sir2 negatively regulates the lifespan extension activity of Sir2. This is in contrast to the title, Abstract, Results and Discussion, which interpret this result to indicate that the phosphorylation promotes lifespan extension. The text needs to be changed to appropriately interpret the data.

2\) *PMA1* expression and H4K16 acetylation was affected by deleting *PDE2*, the high-affinity cAMP phosphodiesterase. This mutant showed hyperphosphorylated Sir2 in [Figure 2G](#fig2){ref-type="fig"}, and this was speculated to alter Sir2 deacetylation activity. If this were the case, then it seems as though Sir2 activity at *HMR* would have been impacted, which it was not. You need to explain your ideas as to why *HMR* silencing was not changed.

3\) The data shown in [Figure 1--figure supplement 3](#fig1s3){ref-type="fig"}, that over expression of SIR2 causes resistance to salt and decreases *PMA1* expression, is an important finding and should be included in the main body of the text/figures.

4\) The data regarding Sas2 and Sir2 do not fit your model and are inconsistent amongst themselves. Figure 1--figure supplement 4D shows that the *sir2∆ sas2∆* double mutant has less H4 K16ac, just like the *sas2∆*. This makes sense. However, the *sir2∆ sas2∆* double mutant has higher H4K16Ac by ChIP and has higher *PMA1* expression. The ChIP data suggest additional HATs for H4K16 at these loci; however the WB suggest that Sas2 is responsible for most of H4K16ac inside the cell. You need to explain what is a likely explanation for this contradiction.

5\) Your proposal that *PMA1* and ribosomal protein gene regulation by Sir2 is a novel mechanism of regulating replicative lifespan and mediating DR effects, would be greatly strengthened by testing whether the *sir2-S473* mutants alter ribosomal DNA recombination/stability. Ideally, you should combine these mutants with a deletion of *FOB1* to stabilize the rDNA and then test if there is still an effect on lifespan.

6\) Does the *S473A* mutant still interact with Cka2-flag through co-IP assays (as in [Figure 3I](#fig3){ref-type="fig"})? According to the triple *TPK* mutant result, it shouldn\'t if phosphorylation at this site is required for the interaction. If it does, there could be other important phosphorylation sites involved. Similarly, they should show that the *S473A* mutant no longer shows the phosphorylation shift on the gel.

7\) The Results and Discussion section is actually all results without any substantial discussion. At a minimum, you need to add an explanation of the proposed model in [Figure 4](#fig4){ref-type="fig"}, and relate the new findings and model to other models of Sir2-mediated gene regulation or lifespan effects.

8\) The actual *P* values for each yeast replicative lifespan assays need to be specifically stated in the figure legends or in a separate table.

9\) For all real-time PCR data (RNA and ChIP), the number of biological replicates *(n)* performed needs to be indicated, to allow the reader to assess the quality and consistency of the data.

10\) In [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}, panel B and C, the NaCl sensitivity by *sir2∆* seems much less than all the other NaCl or monovalent cation sensitivity experiments shown ([Figure 1A, E](#fig1){ref-type="fig"}; [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"};, [Figure 1--figure supplement 2A, C, E](#fig1s2){ref-type="fig"}; [Figure 1--figure supplement 3B](#fig1s3){ref-type="fig"}; Figure 1--figure supplement 4A; [Figure 2A](#fig2){ref-type="fig"}; [Figure 2--figure supplement 1A](#fig2s1){ref-type="fig"} and [Figure 3A, E](#fig3){ref-type="fig"}). What is the cause of inconsistency? Are there other biological replicate experiments showing better consistency?

11\) In Figure 1--figure supplement 4, panel A, the *sas2∆* strain grew poorly on YPD, which is even worse than in NaCl. Is this unexpected result reproducible?

10.7554/eLife.09709.019

Author response

*1) Despite the title, the only experiment on life span extension, in the last figure, is wrongly interpreted. The lifespan data show that phosphorylation of Sir2 negatively regulates the lifespan extension activity of Sir2. This is in contrast to the title, Abstract, Results and Discussion, which interpret this result to indicate that the phosphorylation promotes lifespan extension. The text needs to be changed to appropriately interpret the data*.

To avoid any misunderstanding, we changed the title to: "Sir2 phosphorylation through cAMP-PKA and CK2 signaling inhibits the lifespan extension activity of Sir2 in Yeast". We also rephrased sentences that did not clearly state the negative role of Sir2 S473 phosphorylation in lifespan extension activity of Sir2 (e.g. Abstract, Introduction and subsection "Sir2 S473 phosphorylation inhibits DR-mediated lifespan extension by Sir2").

*2)* PMA1 *expression and H4K16 acetylation was affected by deleting* PDE2*, the high-affinity cAMP phosphodiesterase. This mutant showed hyperphosphorylated Sir2 in* [*Figure 2G*](#fig2){ref-type="fig"}*, and this was speculated to alter Sir2 deacetylation activity. If this were the case, then it seems as though Sir2 activity at* HMR *would have been impacted, which it was not. You need to explain your ideas as to why* HMR *silencing was not changed*.

As the reviewers point out, our data show that cAMP/PKA signaling inhibits the deacetylase activity of Sir2 at *PMA1* and *RPGs*, but not at *HMR* ([Figure 2](#fig2){ref-type="fig"}), which suggests an intriguing hypothesis that the effect of Sir2 phosphorylation through cAMP/PKA signaling may be site-specific. We show that Cka2 phosphorylates Sir2 only at the *PMA1* and *RPL3*, not at other sites including *HMR,* in a cAMP/PKA dependent manner ([Figure 3H, 3I, 3J](#fig3){ref-type="fig"}), although it remains unknown how the specific interaction between Cka2 and Sir2 is regulated. We mentioned this specific regulation in the text (subsection "Sir2 S473 phosphorylation inhibits DR-mediated lifespan extension by Sir2").

*3) The data shown in* [*Figure 1--figure supplement 3*](#fig1s3){ref-type="fig"}*, that over expression of SIR2 causes resistance to salt and decreases* PMA1 *expression, is an important finding and should be included in the main body of the text/figures*.

As suggested, we moved [Figure 1--figure supplement 3](#fig1s3){ref-type="fig"} into the main body of the text/figures ([Figure 1F-H](#fig1){ref-type="fig"}).

*4) The data regarding Sas2 and Sir2 do not fit your model and are inconsistent amongst themselves. Figure 1--figure supplement 4D shows that the* sir2∆ sas2∆ *double mutant has less H4 K16ac, just like the* sas2∆. *This makes sense. However, the* sir2∆ sas2∆ *double mutant has higher H4K16Ac by ChIP and has higher* PMA1 *expression. The ChIP data suggest additional HATs for H4K16 at these loci; however the WB suggest that Sas2 is responsible for most of H4K16ac inside the cell. You need to explain what is a likely explanation for this contradiction*.

As the reviewers' comments, the data in [Figure 1--figure supplement 3](#fig1s3){ref-type="fig"} seem to be inconsistent among themselves. The very low level of H4K16 acetylation shown in [Figure 1--figure supplement 3D](#fig1s3){ref-type="fig"} agrees well with other studies ([@bib31]; [@bib57]). However, [Figure 1--figure supplement 3A-C](#fig1s3){ref-type="fig"} suggest additional HATs replacing Sas2 in the absence of Sir2, although we do not know which HAT acetylates H4K16 in the *sir2*Δ *sas2*Δ mutant. Actually, it is known that Esa1 (Essential SAS family Acetyltransferase) acts as a secondary HAT for H4K16 acetylation in yeast ([@bib6]; [@bib57]; [@bib56]; [@bib5]; Oppikofer et al., 2011, A dual role of H4H6 acetylation in the establishment of yeast silent chromatin. EMBO J. 30: 2610-2621). We mentioned this possibility in the text (subsection "Sir2 negatively regulates *PMA1* transcription by deacetylating H4K16").

*5) Your proposal that* PMA1 *and ribosomal protein gene regulation by Sir2 is a novel mechanism of regulating replicative lifespan and mediating DR effects, would be greatly strengthened by testing whether the* sir2-S473 *mutants alter ribosomal DNA recombination/stability. Ideally, you should combine these mutants with a deletion of* FOB1 *to stabilize the rDNA and then test if there is still an effect on lifespan*.

We analyzed the replicative lifespan (RLS) of *fob1*Δ mutant cells expressing *SIR2-S473E* or *SIR2-S473A*. Under 2.0% glucose conditions, the RLS of the *fob1*Δ cells was decreased by the *sir2-S473E* mutation and increased by the *sir2-S473A* mutation. Under 0.5% glucose conditions, however, the *sir2-S473A* allele no longer extended the RLS of the *fob1*Δ cells. These results are similar with those obtained with *FOB1* cells. Thus, we conclude that the effect of phosphorylation at Sir2 S473 on RLS of yeast cells is independent of rDNA recombination/stability. The data are included in [Figure 4F-4G](#fig4){ref-type="fig"} and in the text (subsection "Sir2 S473 phosphorylation inhibits DR-mediated lifespan extension by Sir2").

*6) Does the* S473A *mutant still interact with Cka2-flag through co-IP assays (as in* [*Figure 3I*](#fig3){ref-type="fig"}*)? According to the triple* TPK *mutant result, it shouldn\'t if phosphorylation at this site is required for the interaction. If it does, there could be other important phosphorylation sites involved. Similarly, they should show that the* S473A *mutant no longer shows the phosphorylation shift on the gel*.

To address the reviewers' question of whether other phosphorylation sites could be involved in the cAMP-PKA-dependent Sir2 phosphorylation, we analyzed the phosphorylation level of the Sir2-S473A protein in the wild type and *pde2*Δ cells. Although Sir2-S473A proteins were still phosphorylated, the Sir2 phosphorylation induced by cAMP-PKA signaling was completely blocked in Sir2-S473A ([Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}). This result suggests that Sir2 S473 is the major residue for Sir2 phosphorylation through cAMP-PKA signaling. The figure is shown as [Figure 2--figure supplement 2](#fig1s2){ref-type="fig"} and explained in the text (subsection "cAMP-PKA signaling inhibits Sir2 activity for the transcriptional repression of *PMA1* through serine 473 phosphorylation.").

*7) The Results and Discussion section is actually all results without any substantial discussion. At a minimum, you need to add an explanation of the proposed model in* [*Figure 4*](#fig4){ref-type="fig"}*, and relate the new findings and model to other models of Sir2-mediated gene regulation or lifespan effects*.

We separated the Results and Discussion section and added some paragraphs discussing the importance of our new findings in the Sirtuin biology field and the possible connection between Sir2 and organelles involved in cellular aging processes (Discussion).

*8) The actual* P *values for each yeast replicative lifespan assays need to be specifically stated in the figure legends or in a separate table*.

As suggested, we provided the *P* values for each yeast replicative lifespan assay in the figure legends ([Figure 4](#fig4){ref-type="fig"} legend).

*9) For all real-time PCR data (RNA and ChIP), the number of biological replicates* (n) *performed needs to be indicated, to allow the reader to assess the quality and consistency of the data*.

As suggested, we provided the number of biological replicates for all real-time PCR data in the figure legends.

*10) In* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"}*, panel B and C, the NaCl sensitivity by* sir2∆ *seems much less than all the other NaCl or monovalent cation sensitivity experiments shown (*[*Figure 1A, E*](#fig1){ref-type="fig"}*;* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"}*;,* [*Figure 1--figure supplement 2A, C, E*](#fig1s2){ref-type="fig"}*;* [*Figure 1--figure supplement 3B*](#fig1s3){ref-type="fig"}*; Figure 1--figure supplement 4A;* [*Figure 2A*](#fig2){ref-type="fig"}*;* [*Figure 2--figure supplement 1A*](#fig2s1){ref-type="fig"} *and* [*Figure 3A, E*](#fig3){ref-type="fig"}*)*. *What is the cause of inconsistency? Are there other biological replicate experiments showing better consistency?*

We agree with the reviewers' observation that the effect of *sir2*∆ mutation on NaCl sensitivity was more pronounced in our wild type background strain than those in other strains. But, LiCl sensitivity was similar (about 10-fold increase in the *sir2* mutant) in all strains ([Figure 1--figure supplement 1A, 1C](#fig1s1){ref-type="fig"}). We repeated these experiments so many times and obtained consistent results. More importantly, the level of *PMA1* mRNA in the *sir2* mutant was consistently higher by about 40% than that in the wild type in all strains, and the amount of the Sir2 protein was increased at least two-fold in all strains tested (we added new western data in [Figure 1--figure supplement 1E](#fig1s1){ref-type="fig"}). Thus, we think that the seemingly inconsistent results are probably due to strain-specific characteristics related to NaCl sensitivity.

*11) In Figure 1--figure supplement 4, panel A*, *the* sas2∆ *strain grew poorly on YPD, which is even worse than in NaCl. Is this unexpected result reproducible?*

Actually, the growth of the *sas2*∆ strain in YPD is not worse than that in NaCl. To avoid the misunderstanding, we optimized the incubation time after spotting and a new picture is now included in [Figure 1--figure supplement 3A](#fig1s3){ref-type="fig"}.
